Symptoms of body dysmorphic disorder among people presenting for cosmetic dental treatment: a comparative study of cosmetic dental patients and a general population sample de Jongh, A.; Aartman, I.H.A.; Parvaneh, H.; Ilik, M. General rightsIt is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), other than for strictly personal, individual use, unless the work is under an open content license (like Creative Commons). Disclaimer/Complaints regulationsIf you believe that digital publication of certain material infringes any of your rights or (privacy) interests, please let the Library know, stating your reasons. In case of a legitimate complaint, the Library will make the material inaccessible and/or remove it from the website. Please Ask the Library: http://uba.uva.nl/en/contact, or a letter to: Library of the University of Amsterdam, Secretariat, Singel 425, 1012 WP Amsterdam, The Netherlands. You will be contacted as soon as possible. AbstractObjectives: To determine appearance concerns of patients presenting for cosmetic treatment. Methods: This cross-sectional comparative study included consecutive patients of six different cosmetic clinics (n = 170), and a sample of the general population (n = 878). A study-specific self report questionnaire was administered to document demographic and appearance concerns. Presence of Body Dysmorphic Disorder (BDD) was assessed based on DSM-IV criteria. Results: Cosmetic dental patients did not differ from the reference sample with regard to happiness, and satisfaction with their appearance. However, differences were found with regard to frequency of previous general cosmetic (16.5 % vs 5.9 %) and cosmetic dental (47.9 % vs 24.8 %) procedures. Furthermore, a significantly higher proportion of the cosmetic dental patients sufficed for the two key screening criteria of BDD (9.5 % vs 5.5 %), and for the full diagnostic screen of BDD (4.2 % vs 1.5 %) compared to the respondents of the reference group. Conclusions: The results suggest that symptoms of BDD are relatively common among patients attending cosmetic clinics. It is important to assess the long-term effects of comprehensive cosmetic procedures, particularly in patients with disproportionate appearance concerns.

The clinical recovery was more pronounced than the electrophysiologic recovery. And surgery is more effective technique than steroid injection for the treatment of the moderate CTS in the long term.

No abstract

The aim of this study was to examine the effects of smartphone use on the median nerve. Materials and Methods: Participants were classified into three groups according to their smartphone use frequencies; high smartphone users (with Smartphone addiction scale (SAS) score of higher than 71), low smartphone users (SAS score less than 71) and classical type mobile phones users. The Visual analogue scale (VAS), quick-disabilities of arm, shoulder, hand (qDASH) and median nerve conductions of the participants were assessed. Groups were compared to each other as well as dominant and non-dominant hand nerve measurements of participants were also compared. Results: VAS and qDASH values were not significantly different between groups. It was observed that the rare use of smartphones affected the median nerve conductions in a lesser manner compared to the classical mobile phone use. However, using smart phone in an increasing rate influenced the median nerves adversely. Conclusion: Excessive use of smartphone can lead to carpal tunnel syndrome via affecting the median nerve. In recent decades, there has been a widespread use of smartphones even at the level of addiction. This should be noted while designing the smartphones and voice applications should be used more often. Furthermore, it can be beneficial to follow up the median nerve conductions of patients who are addicted to smartphones with the help of electrophysiological studies.

Marginal resection remains the best treatment for osteoblastoma of the spine. If tumor tissue surrounds the vertebral artery, the vertebral artery should be mobilized and the surrounding tumor mass excised.

AIm: This study was designed to examine the efficacy of moxonidine, a centrally acting antihypertensive agent that is a selective ligand for I1-imidazoline sites, in a rabbit cerebral vasospasm model. mATERIAl and mEThods: Twenty-four white, male New-Zealand rabbits weighing 2500-3200 gr. were randomly allocated into three groups as group 1= control group, group 2=subarachnoid hemorrhage (SAH) alone group, and group 3=SAH + moxonidine (treatment) group.Cerebral angiography was performed to all rabbits before (Day=0, basal angiography) and 72 hours after the induction of SAH. Intraperitoneal moxonidine (0.5 mg/kg) treatment was started after the induction of SAH and continued once a day for 72 hours in the treatment group.REsulTs: No statistically significant difference was determined in basal angiographic luminal diameter of the basilar artery between groups (p>0.005). After SAH, the follow-up angiographic basilar artery luminal diameter significantly changed in treatment group when compared with the SAH alone group (p<0.001). The pathologically examined basilar artery luminal area was different between these groups (p<0.005). CoNClusIoN:Moxonidine treatment as a centrally acting antihypertensive agent was found to be very beneficial in the treatment of vasospasm by increasing the angiographic diameter and the pathologic luminal area and reducing muscular wall thickness.KEywoRds: Subarachnoid hemorrhage, Cerebral vasospasm, Experimental, Moxonidine, Rabbit ÖZ AmAÇ: Çalışma I1-imidazolin bölgeleri için selektif bir ligand olan merkezi etkili antihipertansif ajan moksonidinin bir tavşan serebral vazospazm modelinde etkinliğini incelemek üzere tasarlanmıştır. yÖNTEm ve GEREÇlER: Yirmi dört beyaz, 2500-3200 gr. ağırlığında erkek, Yeni Zelanda tavşanı rasgele olarak üç gruba bölünmüştür grup 1= kontrol grubu, grup 2=sadece subaraknoid kanama (SAK) grubu ve grup 3=SAK + moksonidin (tedavi) grubu.Tüm tavşanlarda SAK indüksiyonu öncesinde (Gün=0, bazal anjiyografi) ve 72 saat sonrasında serebral anjiyografi yapılmıştır. SAK indüksiyonundan sonra tedavi grubunda intraperitoneal moksonidin (0,5 mg/kg) tedavisi başlatılmış ve günde bir kez olmak üzere 72 saat devam ettirilmiştir.BulGulAR: Gruplar arasında baziller arterin anjiyografik luminal çapı açısından istatistiksel olarak önemli bir fark bulunmamıştır (p>0,005). SAK sonrasında takip anjiyografik baziller arter luminal çapı sadece SAK grubu ile karşılaştırıldığında tedavi grubunda istatistiksel olarak anlamlı şekilde değişiklik göstermiştir (p<0,001). Patolojik olarak incelenen baziller arter lümeni alanı bu iki grup arasında istatistiksel açıdan anlamlı fark göstermiştir (p<0,005).soNuÇ: Merkezi etkili bir antihipertansif ajan olarak moksonidin tedavisi anjiyografik çapı ve patolojide lümen alanını artırıp müsküler duvar kalınlığını azaltarak vazospazm tedavisinde çok faydalı bulunmuştur.

No abstract

Objective: The aim of this study is to examine the outcomes of conservative and surgical treatments of patients with carpal tunnel syndrome as well as the effects of these two treatment options on depressive symptoms of these patients. Methods: A case-control study carried out from June 2015 to Fabruary 2016 and 111 moderate moderate carpal tunnel syndrome patients were included in the study whose diagnosis was confirmed by electroneuromyography (ENMG). The 78 of the patients had surgical treatment and 33 of them, who did not accept the surgery, received steroids via injection and splinting technique was performed for 8 weeks. Boston Carpal Tunnel Questionnaire, quick disabilities of the arm, shoulder and hand score and Beck Depression Invertory scales were applied six months before and after treatments. Results: It was detected that pain functional assessment scores and Beck depression scores significantly recovered the disease in patients who had surgical treatment compared to ones who had the conservative treatment. Conclusions: It can be concluded that surgical treatment plays a more active role in the recovery of depressive symptoms in patients with moderate carpal tunnel syndrome.